NM Aesthetics | Wellness
4201 Wilson Boulevard · Arlington, VA 22203
5.0(713 Google reviews · 98 in past year)
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
4201 Wilson Boulevard · Arlington, VA 22203
5.0(713 Google reviews · 98 in past year)
1530 Wilson Boulevard · Arlington, VA 22209
4.7(622 Google reviews · 66 in past year)
3000 Washington Boulevard · Arlington, VA 22201
5.0(223 Google reviews · 62 in past year)
4820 31st Street South · Arlington, VA 22206
4.5(152 Google reviews · 13 in past year)
1101 South Joyce Street · Arlington, VA 22202
4.8(96 Google reviews · 11 in past year)
932 North Highland Street · Arlington, VA 22201
5.0(58 Google reviews)
2800 Shirlington Road · Arlington, VA 22206
4.2(5 Google reviews · 2 in past year)
46 South Glebe Road · Arlington, VA 22204
3.0(2 Google reviews · 2 in past year)
Pins reflect street addresses where available; others are approximate (ZIP-level).
Be first to know when its status changes — join thousands already on the list.
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Arlington or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 2 of the 10 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Virginia residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.